Impact of Imatinib Intake Timing on Oncological Outcomes in Metastatic Gastrointestinal Stromal Tumors (GISTs): A Retrospective Single-Institute Study.

Cureus · 2026 · PMC13310552 · PMID 42371467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

26.2 months), the timing of imatinib intake did not reach statistical significance as an independent prognostic factor.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.